Ahead of her appearance at eyeforpharma Barcelona, Merck’s director of patient advocacy and strategic partnerships, Vanessa Pott, tells us how the company is approaching patient centric
Researchers rely on a steady stream of volunteers to test and validate their products – yet clinical trial recruitment and retention are significant barriers to success.
